AnalysisNews

NUS today

$4.01+$0.12 (+3.08%)close Nov 12, 2026

Trend

DailyDowntrend (confirmed)

4 hourLeaning Bullish

1 hourBullish

15 minBullish

5 minStrong Bullish

Daily trend turns up above $5.17

Key levels

Resistance$4.88

Resistance$4.61

Latest news & SEC filings

NewsNu Skin Enterprises sets a regular quarterly payout for shareholders

EarningsNu Skin Enterprises Posts Q3 2026 Results

EarningsNu Skin Enterprises holds Q3 2026 earnings call

GuidanceNu Skin Guides Q4 Adjusted EPS to $0.11-$0.21, Sales to $310M-$340M

All NUS news →

About Nu Skin

Nu Skin is a direct selling company that markets personal care products and nutritional supplements through an independent sales force. Its product lines include anti-aging skin care, beauty devices, and wellness items. The company operates in markets across the Americas, Asia, Europe, and Africa. Customers purchase through the company's sales representatives rather than traditional retail stores.

Based on the company's 10-K filed Feb 13, 2026.

NYSE · Healthcare

NU SKIN ENTERPRISES, INC. (NUS)

$4.01+0.12 (+3.08%)
HOLDGrade: CRisk: MEDIUM
1D5D1M1Y5YMaxSign up for all timeframes
4.154.424.684.954.01Oct 12Oct 20Oct 28Nov 5
High4.03
Low3.87
Open3.88
Volume659K
Avg Vol484K
VWAP3.95
30d High5.21
30d Low3.89
30d Chg-13.02%

What Is the Price Target for NUS?

SEPT Low Target

$0.00

SEPT Mid Target

$0.00

SEPT High Target

$0.00

Analyst Consensus

$0.00

Current: $3.89Upside: +0.0%Confidence: 20%Method: No Coverage

Is NUS a Buy or Sell Right Now?

42
Investability Score
HOLD12-18 months
News summary · last 30 days
Nov 5▼ DownEarnings6 articles
Nu Skin Enterprises (NUS) reported third-quarter adjusted EPS of $0.10 and sales of $311.009 million, both missing analyst estimates of $0.21 and $328.700 million, and issued disappointing forward guidance. The company guided Q4 adjusted EPS to $0.11-$0.21 and sales to $310M-$340M, below estimates of $0.27 and $347.5M, while also cutting its FY2026 adjusted EPS outlook to $0.55-$0.65 from $0.70-$0.90 and its sales view to $1.260B-$1.290B from $1.280B-$1.350B. Shares fell sharply on the news, closing at $4.50, down 11.59% from the open of $5.09, with the stock trading between $4.49 and $5.15 on volume of 633,868. The across-the-board earnings misses and reduced guidance signal continued fundamental weakness, pointing to a bearish direction for the stock.

Thesis

  • •Revenue growing -14.3% YoY with DECLINING trend — consistent growth.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for NUS.

Start Free Trial →

Is NUS Overvalued or Undervalued?

Valuation Verdict

UNDERVALUED

Methods Used

P/E Forward, P/B

Fair Value

$22.16

29

Moat Score

NONE

6/9

Piotroski Score

3.5

Altman Z-Score

What Is Smart Money Doing with NUS?

Insider Signal

NEUTRAL

0 buys / 3 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

HIGH

Signal: HIGH_SHORT_INTEREST

Recent Insider Activity

NameTitleTypeSharesValueDate
WOODBURY EDWINA DdirectorBuy19$103.17Jun 10, 2026
Winett James MdirectorSale7,203$40KJun 2, 2026
Winett James MdirectorBuy26,643-Jun 1, 2026
Nathanson LauradirectorBuy26,643-Jun 1, 2026
Zorko Mark AdirectorBuy26,643-Jun 1, 2026
WOODBURY EDWINA DdirectorBuy26,643-Jun 1, 2026
WOODBURY EDWINA DdirectorSale7,203$41KJun 1, 2026
Battle Emma S.directorBuy26,643-Jun 1, 2026
Thomas Pisano R.directorBuy26,643-Jun 1, 2026
CAMPBELL DANIEL WdirectorBuy26,643-Jun 1, 2026

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

NUS Growth Story

Revenue YoY

-14.3%

3yr Revenue CAGR

-12.6%

EPS Growth YoY

207.8%

FCF Growth YoY

-34.4%

Revenue Trend

DECLINING

Dark Pool Trades for NUS

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for NUS, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

TimePriceSizeValueSide
21:23:31$4.011,024$$4KSELL
20:59:48$4.011,000$$4KSELL
20:59:39$4.013,113$$12KBUY
20:59:39$4.011,389$$6KBUY
20:59:06$3.981,528$$6KSELL

5 dark pool trades shown · $$32K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for NU SKIN ENTERPRISES, INC. (NUS) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (0 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

NUS — frequently asked questions

What is NUS stock price today?

NU SKIN ENTERPRISES, INC. (NUS) is at $4.01, up 3.08% (+$0.12) at the Nov 12, 2026 close.

Why is NUS stock moving today?

Latest NUS news — Nov 7, 2026: Nu Skin Enterprises sets a regular quarterly payout for shareholders · Nov 6, 2026: Nu Skin Enterprises Posts Q3 2026 Results

Why did NUS stock move on Nov 5, 2026?

Nu Skin Enterprises (NUS) reported third-quarter adjusted EPS of $0.10 and sales of $311.009 million, both missing analyst estimates of $0.21 and $328.700 million, and issued disappointing forward guidance. The company guided Q4 adjusted EPS to $0.11-$0.21 and sales to $310M-$340M, below estimates of $0.27 and $347.5M, while also cutting its FY2026 adjusted EPS outlook to $0.55-$0.65 from $0.70-$0.90 and its sales view to $1.260B-$1.290B from $1.280B-$1.350B.

Did NUS beat earnings?

NUS last reported on Aug 10, 2026: EPS $0.20 vs $0.20 expected — in line.

Does NUS pay a dividend?

Yes. NUS's dividend yield is 2.50%.

What are NUS support and resistance levels?

Resistance: $4.61, $4.88, $5.15.

What are insiders doing with NUS?

Insider activity: NEUTRAL, 0 buys and 3 sells in the last 90 days.

What is the latest news on NUS?

Nov 7, 2026: Nu Skin Enterprises sets a regular quarterly payout for shareholders · Nov 6, 2026: Nu Skin Enterprises Posts Q3 2026 Results · Nov 5, 2026: Nu Skin Enterprises holds Q3 2026 earnings call